Por: Los Angeles Times Business April 07, 2023
The Food and Drug Administration on Thursday ordered the immediate withdrawal of the only drug meant to prevent preterm birth, saying it's ineffective and risky for pregnant women. “Effective today, Makena and its generics are no longer approved and cannot lawfully be distributed in interstate commerce,” the FDA said in a release. Doctors and pharmacies still have limited supplies of the drug, which is given as a weekly shot to women at... + full article
Associated Press USA Politics April 06, 2023
WASHINGTON (AP) — The Food and Drug Administration on Thursday ordered the immediate market withdrawal of a drug intended to prevent premature births, which has remained available for years despite data showing it .The decision follows repeated efforts by Swiss drugmaker Covis... + más
FDA holds hearing to remove pregnancy drug from market, company pushes back | WGN-TV
FDA panel backs removal of unproven pregnancy drug | Portland Press Herald
WPLG Local 10 USA Politics April 06, 2023
WASHINGTON – The Food and Drug Administration on Thursday ordered the immediate market withdrawal of a drug intended to prevent premature births, which has remained available for years despite data showing it .The decision follows repeated efforts by Swiss drugmaker Covis... + más
ABC News USA Health January 31, 2023
The number of births in the United States increased in 2021 for the , reversing trends that continued during the pandemic, according to new federal data.A published early Tuesday by the Centers for Disease Control and Prevention's National Center for Health Statistics... + más
Home Births Rose During the Pandemic, Study Shows | Time
Home Births Increased in the US During the COVID-19 Pandemic, CDC Data Shows | NBC 6 South Florida
CNN USA Health November 15, 2022
CNN — The rate of premature birth in the United States is climbing, according to the infant and maternal health nonprofit March of Dimes. On Tuesday, the organization released its , which involves a newly updated calculation system. Taking an in-depth look at premature... + más
FDA panel recommends pulling preterm birth drug from the market | The Boston Globe
F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market | The New York Times
The New York Times USA Health October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm births.Makena has been in use for 11 years, and the panel’s vote was widely of... + más
FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC
The Boston Globe USA Nation October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm birth.Makena has been in use for 11 years, and the panel’s vote was widely... + más
CNBC USA Health October 19, 2022
An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.The recommendation, in a 14-1 vote, from the agency's Obstetrics, Reproductive and... + más
FDA panel backs removal of unproven pregnancy drug | WPLG Local 10
ALS drug wins FDA approval despite questionable data | ABC News
About iurex | Privacy Policy | Disclaimer |